UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
June 30, 2023 5:00 P.M.
Form:
S-1
CIK:
0000882361
Company Name:
Aptose Biosciences Inc.
File Number:
333-272752